Related Experiment Video
Updated: Jun 16, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Antithrombotic therapy for ischemic stroke: guidelines translated for the clinician
Anandi Krishnan1, Renato D Lopes, John H Alexander
1Duke Clinical Research Institute, Duke University Medical Center, Box 3850, 27710, Durham, NC, USA.
Journal of Thrombosis and Thrombolysis
|February 4, 2010
Summary
This study reviews 2008 guidelines for acute ischemic stroke care, focusing on fibrinolytic therapy and secondary prevention. It highlights the need for timely treatment and improved public awareness to optimize stroke management.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Emergency Medicine
Background:
- Acute ischemic stroke results from interrupted cerebral blood flow, often due to arterial occlusions.
- Stroke management is complex due to diverse causes and a narrow window for reperfusion therapy.
- Low public awareness of stroke symptoms presents a significant barrier to timely care.
Purpose of the Study:
- To provide a concise overview of current recommendations for acute ischemic stroke management.
- To summarize evidence-based guidelines for fibrinolytic therapy and secondary prevention.
- To review future directions in improving early therapeutic options for stroke.
Main Methods:
- Review of updated major guidelines published in 2008 by leading cardiovascular and stroke organizations.
- Synthesis of recommendations for fibrinolytic therapy in acute ischemic stroke.
- Analysis of antithrombotic therapy strategies for secondary stroke prevention.
Main Results:
- Presents current recommendations for fibrinolytic therapy in acute ischemic stroke.
- Summarizes antithrombotic therapy guidelines for secondary stroke prevention.
- Identifies areas for future research and therapeutic development.
Conclusions:
- Emphasizes the importance of evidence-based care and timely interventions in acute ischemic stroke.
- Highlights the need for improved public awareness and healthcare provider education.
- Underscores the ongoing efforts to enhance therapeutic options for stroke patients.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.